Cancer/testis antigens (CTAs) are a group of tumor antigens expressed in numerous cancer
tissues, as well as in the testis and placental tissues. There are over 200 CTAs supported by …

Cancer‑testis antigen (CTA) is a well‑accepted optimal target library for cancer diagnosis
and treatment. Most CTAs are located on the X chromosome and aggregate into large gene …

Simple Summary Cancer is one of the main causes of death worldwide and early detection
is crucial for effective treatment. Scientists have therefore focused on the identification of …

Next-generation sequencing has enabled patient selection for targeted drugs, some of
which have shown remarkable efficacy in cancers that have the cognate molecular …

Sperm develop from puberty in the seminiferous tubules, inside the blood‐testis barrier to
prevent their recognition as “non‐self” by the immune system, and it is widely assumed that …

A humoral immune response in the form of autoantibodies to tumor antigens occurs early
during tumor development. Identification of antigens that induce an autoantibody response …

Substantial studies indicate that autoantibodies to tumor-associated antigens (TAAbs) arise
in early stage of lung cancer (LC). However, since single TAAbs as non-invasive biomarkers …

Human papillomavirus (HPV) is a common virus, and about 5% of all cancers worldwide is
caused by persistent high-risk HPV infections. Here, we reported a comprehensive analysis …

This study aimed to evaluate the diagnostic efficacy of seven autoantibodies in all lung
cancer, lung adenocarcinoma, lung squamous cell carcinoma and early-stage lung cancer …

Autoantibodies against tumor-associated antigens (TAAbs) can be used as potential
biomarkers in the detection of cancer. Our study aims to identify novel TAAbs for gastric …